Scientific advisory board
![]() |
Professor Kaixian Chen, Ph.D., Medicinal Chemist, Member of Chinese Academy of Sciences, China |
![]() |
Professor Ken-ichi Arai, M.D., Ph.D., Immunologist, Tsukuba University, Japan
|
![]() |
Sir Tom Blundell, FRS, Biochemist, University of Cambridge, UK
|
![]() |
Professor Sunghoon Kim, Ph.D., Molecular Biologist, Seoul National University, Korea
|
![]() |
Mr. Kevin J. Kinsella, M.A., Venture Capitalist, Avalon Ventures, USA
|
![]() |
Mrs. Caryn L. Peterson, International Regulatory Affairs Expert, USA
|
![]() |
Professor K.Vogt, Ph.D., Cell Biologist, the Scripps Research Institute, Member of the National Academy of Sciences, USA
|
![]() |
Dr. Andrew A. Young, M.D., Ph.D., Physiologist,GlaxoSmithKline, USA |
![]() |
Professor Tamas Bartfai, Ph.D., Pharmacologist, the Scripps Research Institute, USA |
![]() |
Professor Patrick M. Sexton, Ph.D., Theme Leader, Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences
Principal Research Fellow, National Health and Medical Research Council of Australia |